• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维化的非纤维成分:基底膜、蛋白聚糖和糖蛋白在心肌纤维化中的作用

The Non-Fibrillar Side of Fibrosis: Contribution of the Basement Membrane, Proteoglycans, and Glycoproteins to Myocardial Fibrosis.

作者信息

Chute Michael, Aujla Preetinder, Jana Sayantan, Kassiri Zamaneh

机构信息

Department of Physiology, Cardiovascular Research Center, University of Alberta, Edmonton, AB T6G 2S2, Canada.

出版信息

J Cardiovasc Dev Dis. 2019 Sep 23;6(4):35. doi: 10.3390/jcdd6040035.

DOI:10.3390/jcdd6040035
PMID:31547598
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6956278/
Abstract

The extracellular matrix (ECM) provides structural support and a microenvironmentfor soluble extracellular molecules. ECM is comprised of numerous proteins which can be broadly classified as fibrillar (collagen types I and III) and non-fibrillar (basement membrane, proteoglycans, and glycoproteins). The basement membrane provides an interface between the cardiomyocytes and the fibrillar ECM, while proteoglycans sequester soluble growth factors and cytokines. Myocardial fibrosis was originally only linked to accumulation of fibrillar collagens, but is now recognized as the expansion of the ECM including the non-fibrillar ECM proteins. Myocardial fibrosis can be reparative to replace the lost myocardium (e.g., ischemic injury or myocardial infarction), or can be reactive resulting from pathological activity of fibroblasts (e.g., dilated or hypertrophic cardiomyopathy). Contribution of fibrillar collagens to fibrosis is well studied, but the role of the non-fibrillar ECM proteins has remained less explored. In this article, we provide an overview of the contribution of the non-fibrillar components of the extracellular space of the heart to highlight the potential significance of these molecules in fibrosis, with direct evidence for some, although not all of these molecules in their direct contribution to fibrosis.

摘要

细胞外基质(ECM)为可溶性细胞外分子提供结构支持和微环境。ECM由多种蛋白质组成,大致可分为纤维状(I型和III型胶原蛋白)和非纤维状(基底膜、蛋白聚糖和糖蛋白)。基底膜在心肌细胞和纤维状ECM之间提供了一个界面,而蛋白聚糖则隔离可溶性生长因子和细胞因子。心肌纤维化最初仅与纤维状胶原蛋白的积累有关,但现在被认为是ECM的扩张,包括非纤维状ECM蛋白。心肌纤维化可以是修复性的,以替代受损的心肌(如缺血性损伤或心肌梗死),也可以是由成纤维细胞的病理活动引起的反应性纤维化(如扩张型或肥厚型心肌病)。纤维状胶原蛋白对纤维化的作用已得到充分研究,但非纤维状ECM蛋白的作用仍较少被探索。在本文中,我们概述了心脏细胞外空间非纤维状成分的作用,以突出这些分子在纤维化中的潜在意义,尽管并非所有这些分子对纤维化的直接贡献都有直接证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d2a/6956278/e80fb0b180ec/jcdd-06-00035-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d2a/6956278/e7a8c78ad788/jcdd-06-00035-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d2a/6956278/e80fb0b180ec/jcdd-06-00035-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d2a/6956278/e7a8c78ad788/jcdd-06-00035-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d2a/6956278/e80fb0b180ec/jcdd-06-00035-g002.jpg

相似文献

1
The Non-Fibrillar Side of Fibrosis: Contribution of the Basement Membrane, Proteoglycans, and Glycoproteins to Myocardial Fibrosis.纤维化的非纤维成分:基底膜、蛋白聚糖和糖蛋白在心肌纤维化中的作用
J Cardiovasc Dev Dis. 2019 Sep 23;6(4):35. doi: 10.3390/jcdd6040035.
2
Cellular and extracellular remodeling with the development and recovery from tachycardia-induced cardiomyopathy: changes in fibrillar collagen, myocyte adhesion capacity and proteoglycans.心动过速性心肌病发生发展及恢复过程中的细胞与细胞外重塑:原纤维胶原蛋白、心肌细胞黏附能力及蛋白聚糖的变化
J Mol Cell Cardiol. 1996 Aug;28(8):1591-608. doi: 10.1006/jmcc.1996.0150.
3
Syndecans in heart fibrosis.心脏纤维化中的 Syndecans蛋白
Cell Tissue Res. 2016 Sep;365(3):539-52. doi: 10.1007/s00441-016-2454-2. Epub 2016 Jul 14.
4
Cellular mechanisms of tissue fibrosis. 2. Contributory pathways leading to myocardial fibrosis: moving beyond collagen expression.细胞组织纤维化的机制。2. 导致心肌纤维化的促成途径:超越胶原表达。
Am J Physiol Cell Physiol. 2013 Mar 1;304(5):C393-402. doi: 10.1152/ajpcell.00347.2012. Epub 2012 Nov 21.
5
Differential impact of mechanical unloading on structural and nonstructural components of the extracellular matrix in advanced human heart failure.机械卸载对晚期人类心力衰竭细胞外基质结构和非结构成分的不同影响。
Transl Res. 2016 Jun;172:30-44. doi: 10.1016/j.trsl.2016.02.006. Epub 2016 Feb 23.
6
Extracellular Matrix in Heart Disease: Focus on Circulating Collagen Type I and III Derived Peptides as Biomarkers of Myocardial Fibrosis and Their Potential in the Prognosis of Heart Failure: A Concise Review.心脏病中的细胞外基质:聚焦循环中的I型和III型胶原衍生肽作为心肌纤维化生物标志物及其在心力衰竭预后中的潜力:简要综述
Metabolites. 2022 Mar 28;12(4):297. doi: 10.3390/metabo12040297.
7
The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.缺血性和非缺血性心力衰竭中的细胞外基质。
Circ Res. 2019 Jun 21;125(1):117-146. doi: 10.1161/CIRCRESAHA.119.311148. Epub 2019 Jun 20.
8
Non-fibrillar collagens: key mediators of post-infarction cardiac remodeling?非纤维胶原:心肌梗死后心脏重构的关键介质?
J Mol Cell Cardiol. 2010 Mar;48(3):530-7. doi: 10.1016/j.yjmcc.2009.06.017. Epub 2009 Jun 30.
9
Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy.细胞外基质纤维化与疾病持续时间有关,但与扩张型心肌病中胶原代谢的动态变化无关。
Inflamm Res. 2016 Dec;65(12):941-949. doi: 10.1007/s00011-016-0977-3. Epub 2016 Aug 11.
10
Extracellular matrix components in retrocorneal fibrous membrane in comparison to corneal endothelium and Descemet's membrane.与角膜内皮和后弹力层相比,角膜后纤维膜中的细胞外基质成分。
Mol Vis. 2000 Mar 7;6:15-23.

引用本文的文献

1
Matrisome remodeling in the myocardium of hypertrophic cardiomyopathy; novel targets for molecular diagnostics.肥厚型心肌病心肌中的基质重塑;分子诊断的新靶点。
Front Cell Dev Biol. 2025 Aug 6;13:1641584. doi: 10.3389/fcell.2025.1641584. eCollection 2025.
2
Circulating microRNAs in predicting fibrosis in hypertrophic cardiomyopathy: A systematic review.循环微RNA在预测肥厚型心肌病纤维化中的应用:一项系统评价
World J Cardiol. 2025 May 26;17(5):106123. doi: 10.4330/wjc.v17.i5.106123.
3
Persistent Transcriptome Alterations in Zebrafish Embryos After Discontinued Opioid Exposure.

本文引用的文献

1
The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.缺血性和非缺血性心力衰竭中的细胞外基质。
Circ Res. 2019 Jun 21;125(1):117-146. doi: 10.1161/CIRCRESAHA.119.311148. Epub 2019 Jun 20.
2
Cathepsin S degrades arresten and canstatin in infarcted area after myocardial infarction in rats.组织蛋白酶S可降解大鼠心肌梗死后梗死区域的抑制素和内皮抑素。
J Vet Med Sci. 2019 Apr 16;81(4):522-531. doi: 10.1292/jvms.18-0674. Epub 2019 Feb 7.
3
Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology.
阿片类药物暴露停止后斑马鱼胚胎中持续的转录组改变。
Int J Mol Sci. 2025 May 19;26(10):4840. doi: 10.3390/ijms26104840.
4
Organ fibrosis: beyond collagen I expression. Fibroblast phenotype and basement membrane proteins.器官纤维化:超越I型胶原蛋白表达。成纤维细胞表型与基底膜蛋白
Am J Physiol Cell Physiol. 2025 Jun 1;328(6):C2023-C2031. doi: 10.1152/ajpcell.00077.2025. Epub 2025 May 12.
5
Anti-fibrosis effect of astragaloside IV in animal models of cardiovascular diseases and its mechanisms: a systematic review.黄芪甲苷在心血管疾病动物模型中的抗纤维化作用及其机制:一项系统评价
Pharm Biol. 2025 Dec;63(1):250-263. doi: 10.1080/13880209.2025.2488994. Epub 2025 Apr 22.
6
Developments in Extracellular Matrix-Based Angiogenesis Therapy for Ischemic Heart Disease: A Review of Current Strategies, Methodologies and Future Directions.基于细胞外基质的缺血性心脏病血管生成疗法的进展:当前策略、方法及未来方向综述
BioTech (Basel). 2025 Mar 19;14(1):23. doi: 10.3390/biotech14010023.
7
Harnessing native blueprints for designing bioinks to bioprint functional cardiac tissue.利用天然蓝图设计生物墨水以生物打印功能性心脏组织。
iScience. 2025 Jan 23;28(3):111882. doi: 10.1016/j.isci.2025.111882. eCollection 2025 Mar 21.
8
Deficiency in nucleoside diphosphate kinase B leads to endothelial activation of the hexosamine biosynthesis pathway and cardiac dysfunction.核苷二磷酸激酶B缺乏会导致己糖胺生物合成途径的内皮激活和心脏功能障碍。
Cardiovasc Diabetol. 2025 Feb 21;24(1):84. doi: 10.1186/s12933-025-02633-8.
9
Rescue of mitochondrial dysfunction through alteration of extracellular matrix composition in barth syndrome cardiac fibroblasts.通过改变巴氏综合征心脏成纤维细胞的细胞外基质组成来挽救线粒体功能障碍
Biomaterials. 2025 Apr;315:122922. doi: 10.1016/j.biomaterials.2024.122922. Epub 2024 Oct 26.
10
The Extracellular Matrix and Cardiac Pressure Overload: Focus on Novel Treatment Targets.细胞外基质与心脏压力超负荷:关注新的治疗靶点。
Cells. 2024 Oct 12;13(20):1685. doi: 10.3390/cells13201685.
为了更好地定义、量化和治疗心力衰竭中的纤维化。欧洲心脏病学会心力衰竭协会(HFA)转化研究委员会的科学路线图。
Eur J Heart Fail. 2019 Mar;21(3):272-285. doi: 10.1002/ejhf.1406. Epub 2019 Feb 4.
4
Thrombospondin-3 augments injury-induced cardiomyopathy by intracellular integrin inhibition and sarcolemmal instability.血小板反应蛋白-3 通过细胞内整合素抑制和肌膜不稳定加剧损伤诱导的心肌病。
Nat Commun. 2019 Jan 8;10(1):76. doi: 10.1038/s41467-018-08026-8.
5
Disparate Remodeling of the Extracellular Matrix and Proteoglycans in Failing Pediatric Versus Adult Hearts.在衰竭的儿科与成人心脏中细胞外基质和蛋白聚糖的不同重塑。
J Am Heart Assoc. 2018 Oct 2;7(19):e010427. doi: 10.1161/JAHA.118.010427.
6
Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.心脏纤维化:细胞生物学机制、分子途径和治疗机会。
Mol Aspects Med. 2019 Feb;65:70-99. doi: 10.1016/j.mam.2018.07.001. Epub 2018 Aug 2.
7
The matrix proteins aggrecan and fibulin-1 play a key role in determining aortic stiffness.聚集蛋白聚糖和纤连蛋白-1 等基质蛋白在决定主动脉僵硬度方面起着关键作用。
Sci Rep. 2018 Jun 4;8(1):8550. doi: 10.1038/s41598-018-25851-5.
8
Thrombospondin-1 promotes matrix homeostasis by interacting with collagen and lysyl oxidase precursors and collagen cross-linking sites.血小板反应蛋白-1 通过与胶原蛋白和赖氨酰氧化酶前体以及胶原蛋白交联位点相互作用,促进基质稳态。
Sci Signal. 2018 May 29;11(532):eaar2566. doi: 10.1126/scisignal.aar2566.
9
Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling.赋予基质金属蛋白酶在缺血性心脏重构中的作用。
Nat Rev Cardiol. 2018 Aug;15(8):471-479. doi: 10.1038/s41569-018-0022-z.
10
Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.抑制纤维连接蛋白可减轻心力衰竭模型中的纤维化并改善心功能。
Circulation. 2018 Sep 18;138(12):1236-1252. doi: 10.1161/CIRCULATIONAHA.118.034609.